• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自非脆弱拟杆菌属的β-内酰胺酶的特性,该属包括七个物种及其在β-内酰胺耐药性中的作用。

Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance.

作者信息

Appelbaum P C, Philippon A, Jacobs M R, Spangler S K, Gutmann L

机构信息

Université Pierre et Marie Curie, Paris, France.

出版信息

Antimicrob Agents Chemother. 1990 Nov;34(11):2169-76. doi: 10.1128/AAC.34.11.2169.

DOI:10.1128/AAC.34.11.2169
PMID:2073107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC172019/
Abstract

Twelve beta-lactamase-positive non-Bacteroides fragilis group Bacteroides spp. belonging to seven different species were examined by MIC determination and enzyme characterization. MICs of most beta-lactams except cefoxitin, cefotetan, imipenem, and meropenem were relatively high or very high. All enzymes hydrolyzed cephaloridine (Vmax, 100%; Km, 12 to 70 microM), cephalothin (Vmax, 25 to 826%; Km, 8 to 143 microM), cefamandole (Vmax, 13 to 158%; Km, 17 to 170 microM), and cefuroxime (hydrolysis rate, 19 to 98%), and 11 of 12 hydrolyzed cefotaxime (Vmax, 26 to 145%; Km, 13 to 127 microM); no hydrolysis of cefoxitin or moxalactam was observed. Penicillins were hydrolyzed at lower rates, with Vmax values less than or equal to 20% of that obtained with cephaloridine. Addition of clavulanate, sulbactam, or tazobactam led to a 4- to 2,048-fold lowering of MICs of penicillins as well as cephalosporins. All enzymes were inhibited by clavulanate (50% inhibitory concentration [IC50], 0.01 to 1.8 microM), sulbactam (IC50, 0.02 to 1.9 microM), tazobactam (IC50, 0.001 to 0.9 microM), cefoxitin (IC50, 0.002 to 0.35 microM), and moxalactam (IC50, 0.03 to 6.6 microM). No enzymes were inhibited by 100 microM EDTA or p-chloromercuribenzoic acid; an enzyme of one strain of B. loescheii was inhibited by 100 microM cloxacillin (IC50, 2.35 microM). Ten enzymes had optimal activity at pH 5.0 to 6.0, and two had optimal activity at pH 8.0. Isoelectric focusing revealed pIs between 4.2 and 5.6. These enzymes seem to belong to a previously unclassified group of beta-lactamases, related (but not identical) to beta-lactamases of the B. fragilis group.

摘要

对属于七个不同种的12株β-内酰胺酶阳性非脆弱拟杆菌属拟杆菌进行了最低抑菌浓度(MIC)测定和酶特性分析。除头孢西丁、头孢替坦、亚胺培南和美罗培南外,大多数β-内酰胺类药物的MIC相对较高或非常高。所有酶均能水解头孢菌素(Vmax,100%;Km,12至70μM)、头孢噻吩(Vmax,25至826%;Km,8至143μM)、头孢孟多(Vmax,13至158%;Km,17至170μM)和头孢呋辛(水解率,19至98%),12株中有11株能水解头孢噻肟(Vmax,26至145%;Km,13至127μM);未观察到头孢西丁或拉氧头孢的水解。青霉素的水解率较低,Vmax值小于或等于头孢菌素的20%。添加克拉维酸、舒巴坦或他唑巴坦可使青霉素和头孢菌素的MIC降低4至2048倍。所有酶均被克拉维酸(50%抑制浓度[IC50],0.01至1.8μM)、舒巴坦(IC50,0.02至1.9μM)、他唑巴坦(IC50,0.001至0.9μM)、头孢西丁(IC50,0.002至0.35μM)和拉氧头孢(IC50,0.03至6.6μM)抑制。没有酶被100μM乙二胺四乙酸(EDTA)或对氯汞苯甲酸抑制;1株洛氏拟杆菌的酶被100μM氯唑西林抑制(IC50,2.35μM)。10种酶在pH 5.0至6.0时具有最佳活性,2种酶在pH 8.0时具有最佳活性。等电聚焦显示pI在4.2至5.6之间。这些酶似乎属于以前未分类的β-内酰胺酶组,与脆弱拟杆菌组的β-内酰胺酶相关(但不相同)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d8/172019/f4e6e2ce199b/aac00067-0158-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d8/172019/f4e6e2ce199b/aac00067-0158-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d8/172019/f4e6e2ce199b/aac00067-0158-a.jpg

相似文献

1
Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance.来自非脆弱拟杆菌属的β-内酰胺酶的特性,该属包括七个物种及其在β-内酰胺耐药性中的作用。
Antimicrob Agents Chemother. 1990 Nov;34(11):2169-76. doi: 10.1128/AAC.34.11.2169.
2
Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility.二路拟杆菌β-内酰胺酶在β-内酰胺敏感性中的作用。
Antimicrob Agents Chemother. 1984 Nov;26(5):694-8. doi: 10.1128/AAC.26.5.694.
3
Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.394株脆弱拟杆菌、非脆弱拟杆菌属拟杆菌种及梭杆菌属细菌对新型抗菌药物的敏感性
Antimicrob Agents Chemother. 1991 Jun;35(6):1214-8. doi: 10.1128/AAC.35.6.1214.
4
Characterization of a beta-lactamase from Clostridium clostridioforme.来自艰难梭状芽孢杆菌的一种β-内酰胺酶的特性分析。
J Antimicrob Chemother. 1994 Jan;33(1):33-40. doi: 10.1093/jac/33.1.33.
5
Biochemical properties of beta-lactamase produced by Bacteroides distasonis.
J Antibiot (Tokyo). 1989 Jun;42(6):960-7. doi: 10.7164/antibiotics.42.960.
6
Characterization of beta-lactamases in clinical isolates of Bacteroides.拟杆菌临床分离株中β-内酰胺酶的特性分析
J Antimicrob Chemother. 1986 Sep;18(3):325-33. doi: 10.1093/jac/18.3.325.
7
beta-Lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents.美国和欧洲厌氧革兰氏阴性杆菌的β-内酰胺酶产生情况及其对β-内酰胺类药物和其他药物的敏感性
Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1081-93. doi: 10.1007/BF01967803.
8
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.来自美国28个中心的320株非脆弱拟杆菌属拟杆菌分离株和129株梭杆菌属细菌的β-内酰胺酶产生情况以及对阿莫西林、阿莫西林-克拉维酸、替卡西林、替卡西林-克拉维酸、头孢西丁、亚胺培南和甲硝唑的敏感性。
Antimicrob Agents Chemother. 1990 Aug;34(8):1546-50. doi: 10.1128/AAC.34.8.1546.
9
An investigation of beta-lactamases from clinical isolates of Bacteroides species.对拟杆菌属临床分离株中β-内酰胺酶的研究。
J Med Microbiol. 1992 Feb;36(2):89-95. doi: 10.1099/00222615-36-2-89.
10
In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.N-甲脒硫霉素、噻肟单酰胺菌素及其他新型β-内酰胺类药物对脆弱拟杆菌的体外活性:β-内酰胺酶对耐药性的作用
Antimicrob Agents Chemother. 1981 Feb;19(2):248-52. doi: 10.1128/AAC.19.2.248.

引用本文的文献

1
Intestinal Exposure to Ceftiofur and Cefquinome after Intramuscular Treatment and the Impact of Ceftiofur on the Pig Fecal Microbiome and Resistome.肌肉注射治疗后头孢噻呋和头孢喹肟在肠道中的暴露情况以及头孢噻呋对猪粪便微生物组和耐药组的影响。
Antibiotics (Basel). 2022 Mar 4;11(3):342. doi: 10.3390/antibiotics11030342.
2
The Brief Case: Retropharyngeal Abscess in a 14-Year-Old Caused by Fusobacterium necrophorum.病例摘要:一名14岁青少年因坏死梭杆菌引起的咽后脓肿
J Clin Microbiol. 2018 Nov 27;56(12). doi: 10.1128/JCM.00487-18. Print 2018 Dec.
3
Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik's Cube of Clinical Microbiology?

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Purification and some properties of a cephalosporinase from Proteus vulgaris.普通变形杆菌中一种头孢菌素酶的纯化及某些特性
Antimicrob Agents Chemother. 1981 Jan;19(1):185-7. doi: 10.1128/AAC.19.1.185.
3
Properties of a new penicillinase type produced by Bacteroides fragilis.脆弱拟杆菌产生的一种新型青霉素酶的特性
厌氧菌的鉴定及药敏试验:临床微生物学的魔方?
Antibiotics (Basel). 2017 Nov 7;6(4):25. doi: 10.3390/antibiotics6040025.
4
Cephalosporinases associated with outer membrane vesicles released by Bacteroides spp. protect gut pathogens and commensals against β-lactam antibiotics.与拟杆菌属释放的外膜囊泡相关的头孢菌素酶可保护肠道病原体和共生菌免受β-内酰胺抗生素的影响。
J Antimicrob Chemother. 2015 Mar;70(3):701-9. doi: 10.1093/jac/dku466. Epub 2014 Nov 27.
5
Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries.通过筛选具有药理活性的化合物库和点击化学化合物库来寻找波形蛋白-2(VIM-2)的抑制剂。
Bioorg Med Chem. 2009 Jul 15;17(14):5027-37. doi: 10.1016/j.bmc.2009.05.070. Epub 2009 Jun 22.
6
Antianaerobic activity of sulopenem compared to six other agents.与其他六种药物相比,舒洛培南的抗厌氧活性。
Antimicrob Agents Chemother. 2009 May;53(5):2163-70. doi: 10.1128/AAC.01557-08. Epub 2009 Feb 17.
7
Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.一名患有心内膜炎患者体内一株对达托霉素不敏感的万古霉素中介金黄色葡萄球菌菌株的特征分析。
Antimicrob Agents Chemother. 2007 Sep;51(9):3445-8. doi: 10.1128/AAC.00559-07. Epub 2007 Jul 9.
8
Antianaerobic activity of a novel fluoroquinolone, WCK 771, compared to those of nine other agents.新型氟喹诺酮类药物WCK 771与其他九种药物的抗厌氧活性比较。
Antimicrob Agents Chemother. 2004 Aug;48(8):3188-92. doi: 10.1128/AAC.48.8.3188-3192.2004.
9
Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents.新型恶唑烷酮类药物RBX 7644(瑞苯唑酮)与其他八种药物的抗厌氧菌活性比较。
Antimicrob Agents Chemother. 2003 Mar;47(3):1143-7. doi: 10.1128/AAC.47.3.1143-1147.2003.
10
Comparative antianaerobic activity of BMS 284756.BMS 284756的抗厌氧活性比较
Antimicrob Agents Chemother. 2001 Feb;45(2):589-92. doi: 10.1128/AAC.45.2.589-592.2001.
Antimicrob Agents Chemother. 1982 Oct;22(4):579-84. doi: 10.1128/AAC.22.4.579.
4
Resistance to beta-lactam antibiotics in Bacteroides species.拟杆菌属中对β-内酰胺类抗生素的耐药性。
J Antimicrob Chemother. 1981 Dec;8 Suppl D:33-42. doi: 10.1093/jac/8.suppl_d.33.
5
The contribution of beta-lactamases to beta-lactam resistance in Bacteroides fragilis.β-内酰胺酶对脆弱拟杆菌β-内酰胺耐药性的作用。
J Antimicrob Chemother. 1982 Jan;9(1):29-45. doi: 10.1093/jac/9.1.29.
6
Beta-lactamase-producing Bacteroides species in the oral cavity in relation to penicillin therapy.口腔中产β-内酰胺酶拟杆菌属与青霉素治疗的关系。
J Antimicrob Chemother. 1981 Sep;8(3):225-9. doi: 10.1093/jac/8.3.225.
7
The beta-lactamases of Bacteroides species.
J Antimicrob Chemother. 1981 Feb;7(2):137-46. doi: 10.1093/jac/7.2.137.
8
Characterization of three different beta-lactamases from the Bacteroides fragilis group.脆弱拟杆菌群中三种不同β-内酰胺酶的特性分析。
Antimicrob Agents Chemother. 1980 Aug;18(2):220-5. doi: 10.1128/AAC.18.2.220.
9
Purification and properties of a new beta-lactamase from Pseudomonas cepacia.洋葱伯克霍尔德菌新型β-内酰胺酶的纯化及性质
Antimicrob Agents Chemother. 1980 Mar;17(3):355-8. doi: 10.1128/AAC.17.3.355.
10
Beta-lactamase-producing isolates of Bacteroides species from children.来自儿童的产β-内酰胺酶类杆菌属分离株。
Antimicrob Agents Chemother. 1980 Jul;18(1):164-6. doi: 10.1128/AAC.18.1.164.